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Abstract
Purpose—Pigs expressing neither galactose-α1,3-galactose (Gal) nor N-glycolylneuraminic acid 
(NeuGc) take xenotransplantation one step closer to the clinic. Our aims were (i) to document the 
lack of NeuGc expression on corneas and aortas, and cultured endothelial cells (aortic [AECs]; 
corneal [CECs]) of GTKO/NeuGcKO pigs, and (ii) to investigate whether the absence of NeuGc 
reduced human antibody binding to the tissues and cells.
Methods—Wild-type (WT), GTKO, and GTKO/NeuGcKO pig were used for the study. Human 
tissues and cultured cells were negative controls. Immunofluorescence staining was performed 
using anti-Gal and anti-NeuGc antibodies, and to determine human IgM and IgG binding to 
tissues. Flow cytometric analysis was used to determine Gal and NeuGc expression on cultured 
CECs and AECs and to measure human IgM/IgG binding to these cells.
Results—Both Gal and NeuGc were detected on WT pig corneas and aortas. Although GTKO 
pigs expressed NeuGc, neither human nor GTKO/NeuGcKO pigs expressed Gal or NeuGc. 
Human IgM/IgG binding to corneas and aortas from GTKO and GTKO/NeuGcKO pigs was 
reduced compared to binding to WT pigs. Human antibody binding to GTKO/NeuGcKO AECs 
was significantly less than to GTKO AECs, but there was no significant difference in binding 
between GTKO and GTKO/NeuGcKO CECs.
Conclusions—The absence of NeuGc on GTKO aortic tissue and AECs is associated with 
reduced human antibody binding, and possibly will provide better outcome in clinical 
xenotransplantation using vascularized organs. For clinical corneal xenotransplantation, the 
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absence of NeuGc expression on GTKO/NeuGcKO pig corneas may not prove an advantage over 
GTKO corneas.
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Xenotransplantation
INTRODUCTION
The production of α1,3-galactosyltransferase gene-knockout (GTKO) pigs in 2003 was a 
significant advance in the development of xenotransplantation1. In 2013, pigs that lacked 
two major carbohydrate xenoantigens, galactose-α1,3-galactose (Gal) and N-
glycolylneuraminic acid (NeuGc), were introduced (GTKO/NeuGcKO pigs)2. The absence 
of expression of NeuGc (NeuGcKO pigs) further reduced the xenoantigenicity of pig 
peripheral blood mononuclear cells (PBMCs) when exposed to human serum, since a 
significant fraction of human anti-nonGal antibodies is known to be specific for 
carbohydrate structures with terminal NeuGc3. Most pig organs, except for neural tissue, 
express NeuGc4, and the extent of expression is similar to, or greater than, the Gal antigen5. 
Furthermore, almost all healthy humans develop anti-NeuGc antibody3,6, in part due to 
exposure to dietary NeuGc7. For the purposes of clinical xenotransplantation, the need to 
delete expression of NeuGc was first suggested by Bouhours et al in 19968.
In 2013, the first GTKO/NeuGcKO pigs were successfully produced by zinc-finger nuclease 
technology2. Binding of human serum IgM and IgG to GTKO/NeuGcKO pig PBMCs was 
significantly reduced when compared to binding to GTKO pig PBMCs2,9. However, there is 
no definitive report using other primary cultured cells so far. We have now investigated 
NeuGc expression on wild-type (WT) and GTKO pig corneas and aortas and have compared 
IgM and IgG antibody binding to these tissues.
The cornea is an unusual tissue in terms of its immunologic features, e.g., avascularity, weak 
expression of major histocompatibility complex antigens, and presence of 
immunomodulating molecules in the aqueous humor10. Despite these advantageous features, 
the antigenicity of the pig cornea remains a major barrier to successful xenotransplantation. 
Nevertheless, the immunologic characteristics of corneas may be different from those of 
other organs.
Both anti-Gal11 and anti-nonGal12 antibody production have been reported in the pig-to-
monkey corneal transplantation model, especially when the graft is rejected. Human patients 
grafted with pig skin13 or ligaments14 develop high titers of anti-nonGal antibodies. The 
expression of the sialic acids, N-acetylneuraminic (NeuAc) acid and NeuGc, varies between 
different pig tissues and cells. These oligosaccharides can be present as glycoprotein or 
glycolipid5.
Previously, we reported the presence and distribution of Gal and NeuGc on WT and GTKO 
porcine corneas by immunofluorescence staining15. Gal is mainly expressed on the stromal 
keratocytes (and weakly on the stroma), with no expression on the corneal epithelium or 
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endothelium in naïve status (i.e., when the cornea is not activated). However, WT pig 
corneal endothelial cells (CECs) develop Gal epitopes in certain situations (e.g., during in 
vitro culture16, or when exposed to inflammatory cytokines after xenotransplantation)17. In 
contrast to Gal, NeuGc is expressed on corneal epithelium and endothelium in addition to 
stromal keratocytes18. Since healthy CECs are essential to corneal transparency, and thus 
good vision, after corneal transplantation they represent the most important structures. 
Antibody binding to the CECs may result in significant injury.
Our aims in the present study were (i) to document the absence of Gal and NeuGc 
expression on the cornea as well as aorta, and on cultured cells, from GTKO/NeuGcKO 
pigs, (ii) to compare human IgM and IgG binding to corneas and aortic tissues from these 
pigs with binding to WT and GTKO pig and human corneas and aortic tissues, and (iii) to 
compare this binding to that to cultured cells (aortic endothelial cells [AECs]; corneal 
endothelial cells [CECs]) from WT, GTKO, and GTKO/NeuGcKO pigs and humans.
MATERIALS AND METHODS
Preparation of corneas
All procedures used in this study conformed to the ARVO Statement for the Use of Animals 
in Ophthalmic and Vision Research. In addition, all in vitro human study protocols were 
approved by the Research Ethics Committee at the University of Pittsburgh. The samples 
were obtained in accordance with the Declaration of Helsinki. Participants gave informed 
consent per the guidelines of the Institutional Review Board of the University of Pittsburgh 
(IRB0608179).
Eyes from 6 month-old WT (Large White) pigs (n=3) were obtained from a local 
slaughterhouse. Eyes from GTKO pigs (on a Large White background) were obtained from 
Revivicor (Blacksburg, VA; n=3) and from GTKO pigs (on a mixed background, NSRRC;
0009) from the National Swine Resource and Research Center (NSRRC, Columbia, MO; 
n=2). All GTKO pigs were the result of natural breeding, with the original founder pigs 
derived from nuclear transfer/embryo transfer.
Eyes from GTKO/NeuGcKO pigs (by zinc finger nuclease technology on a Yorkshire/
Chester White background) were provided by the Department of Surgery, Indiana University 
School of Medicine (Indianapolis, IN; n=2), and eyes from GTKO/NeuGcKO pigs (by 
nuclear transfer/embryo transfer on a Large White background) were provided by Revivicor 
(n=6).
Corneas from deceased humans (blood type O) that were not suitable for clinical 
transplantation were provided by the Pittsburgh Center for Organ Recovery and Education 
(CORE) with the approval of the University of Pittsburgh Committee for Oversight of 
Research Involving the Dead (CORID No.231), and in accordance with the guidelines of the 
Declaration of Helsinki for research involving the use of human tissues16.
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Preparation of cultured corneal endothelial cells (CECs)
The eye globes were maintained in sterile wet gauze until the corneas were excised (with at 
least 1mm of surrounding sclera). From each pair of corneas, one was embedded in optimal 
cutting temperature compound (Tissue-Tek, Miles Laboratories, Naperville, IL), frozen, and 
sectioned for immunofluorescence staining. The other provided CECs. Pig and human CECs 
were isolated, cultured, and passaged as previously described19 and used after passage 2 to 
4.
Preparation of aortas and cultured aortic endothelial cells (AECs)
Thoracic aortas from all of the above pigs were obtained, and pig (p) AECs were cultured 
and passaged as previously described20. All cells were cultured in collagen-I-coated 25- or 
75-cm2 tissue culture flasks (BD Biosciences, San Jose, CA).
Immunofluorescence staining for Gal and NeuGc on corneas and aortas
Staining for expression of Gal and NeuGc was carried out as previously described15. Gal 
staining was with fluorescein isothiocyanate (FITC)-conjugated BSI-B4 lectiin (isolectin B4 
from Bandeiraea simplicifolia; 10 mg/mL; Sigma–Aldrich, St. Louis, MO). NeuGc staining 
was with a chicken-derived anti-NeuGc immunohistochemistry kit (Sialix, Cambridge, MA), 
following the manufacturer's instructions. DAPI (4,6-diamidino-2-phenylindole, Invitrogen, 
Waltham, MA) stained nuclei in all cases.
Immunofluorescence staining for human IgM and IgG binding to corneas and aortas
IgM and IgG binding assays using human serum were carried out as previously described15. 
Heat-inactivated pooled serum from healthy human volunteers (n=5, including all ABO 
blood types) was diluted to 20% for IgM and to 5% for IgG binding. Corneal or aortic 
tissues were incubated with pooled human serum for 60min at room temperature. Phosphate 
buffered serum (PBS; Invitrogen) was used as a negative control. The slides were then 
washed with PBS and blocked with 10% goat serum for 30min at room temperature. FITC-
conjugated goat-derived anti-human IgM (μ chain– specific) or IgG (γ chain–specific) 
polyclonal antibody (concentration 1:100; Invitrogen) was applied for 30min at room 
temperature for detection of IgM or IgG binding. DAPI was applied for nuclear staining and 
the slides were examined by fluorescence microscopy (Nikon, Tokyo, Japan).
Flow cytometric analysis for Gal and NeuGc expression on, and human IgM/IgG binding to, 
cultured CECs and AECs
Surface expression of Gal and NeuGc, and human IgM/IgG binding to CECs and AECs 
were detected by flow cytometry (BD LSR II; BD Biosciences), as previously described16. 
Serum samples from healthy human volunteers (n=7, including all ABO blood types) were 
pooled. CECs or AECs were diluted to 105 cells per tube in FACS buffer (PBS containing 
1% BSA and 0.1% NaN3). The antibodies used for immunofluorescence staining were also 
used for the detection of antibody binding.
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Statistical methods
The statistical significance of differences was determined by Student's t or nonparametric 
tests, as appropriate, using GraphPad Prism version 4 (GraphPad Software, San Diego, CA). 
Values are presented with mean value. Differences were considered to be significant at 
p<0.05.
RESULTS
Expression of Gal and NeuGc by immunofluorescence or flow cytometry
The tissue structure and cell morphology of corneas from genetically-engineered pigs, 
including GTKO/NeuGcKO pigs, were not different from those of WT pigs20 (data not 
shown). WT pig corneas and aortas expressed Gal (Fig. 1A,C) and NeuGc (Fig.1B,C) as did 
CECs (Fig. 2A,B). GTKO pig corneas and aortas (from pigs of two different genetic 
backgrounds) were negative for Gal expression, but positive for NeuGc (Fig. 1A,B,C), as 
were GTKO CECs (Fig. 2A,B) and AECs (Fig. 2C,D).
By flow cytometry, the expression level of NeuGc on CECs from GTKO pigs from the 
NSRRC was higher than on CECs from GTKO pigs from Revivicor and WT corneas (the 
rMFI of two NSRRC pigs was 9.7 and 21.6, respectively, and of three Revivicor pigs, 4.3, 
6.3 and 4.4, respectively [Fig. 3A]), though statistical analysis could not be carried out due 
to the small number of corneas tested. Similar to CECs, the expression level of NeuGc on 
AECs from the NSRRC was higher than on AECs of GTKO pigs from Revivicor and WT 
aortas (Fig. 3B). GTKO/NeuGcKO pig corneas, aortas (Fig. 1), cultured pCECs (Fig. 2A,B) 
and pAECs (from both sources, Fig. 2C,D) did not express either Gal or NeuGc, as was the 
case for human corneas and CECs (Fig. 1,2).
Human IgM and IgG antibody binding to corneas and aortas by immunofluorescence
Compared to binding to WT pig corneas, human IgM and IgG binding to GTKO pig corneas 
was decreased (Fig. 4A,B). Fluorescence intensity appeared even less to GTKO/NeuGcKO 
pig corneas, particularly to the endothelium, but there was still some binding when 
compared to human corneas (Fig. 4A,B). Human IgM and IgG bound primarily to 
endothelium of pig aortic tissue (Fig. 4C), and appeared to be related to expression of 
NeuGc epitopes. Compared to binding to WT pig aortas, human IgM and IgG binding to 
GTKO pig aortas was greatly decreased, especially to endothelium, and it was further 
decreased to GTKO/NeuGcKO pig aortas (Fig. 4C).
Human IgM and IgG antibody binding to CECs and AECs by flow cytometry
Binding of human IgM and IgG to GTKO pCECs was greatly reduced compared to that to 
WT pCECs (Fig. 5A,B). There was no obvious difference in human IgM/IgG binding to the 
CECs from GTKO pigs (from 2 different genetic backgrounds) and GTKO/NeuGcKO pigs 
(from 2 different genetic backgrounds). In contrast to pCECs, there was significant further 
reduction of human IgM/IgG binding to GTKO/NeuGcKO pAECs in comparison to GTKO 
pAECs (Fig. 5C,D). There was no significant difference in binding to pAECs from the two 
different types of GTKO pig or GTKO/NeuGcKO pig.
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DISCUSSION
Neither Gal nor NeuGc could be detected in corneas/CECs (or aortas/AECs) from GTKO/
NeuGcKO pigs, as is the case with human corneas and aortas. Nevertheless, some human 
antibodies, noticeably IgG, bound to the corneas and aortas, suggesting that there are 
remaining xenoantigens on GTKO/NeuGcKO pig corneas and aortas, as suggested by 
others22. An antibody directed to nonGal/nonNeuGc antigens has been proposed23, but its 
specificity remains unknown. Byrne et al have identified β1,4 N-acetylgalactosaminyl 
transferase as an antigen of significance in xenotransplantation24, but its relevance to corneal 
transplantation is unknown. Whether antibody binding to non-Gal, non-NeuGc epitopes on a 
corneal graft (or other organ) would be detrimental to its long-term outcome needs to be 
investigated.
A higher expression of NeuGc has been demonstrated on GTKO pig tissue (i.e., heart, liver, 
kidney) and cells (fibroblast cells) compared to NeuGc expression on WT cells, suggesting 
that deletion of the α1,3-galactosyltransferase gene leads to a ‘compensatory’ increased 
expression of sialylated glycans, including NeuGc 25,26. In contrast, in our previous 
experience we did not document any difference in expression of NeuGc between WT and 
GTKO pig corneas by immunofluorescence staining15. However, in the present study, by 
flow cytometry we detected varying levels of expression of NeuGc depending on the genetic 
background of the pig. Cells (both pAECs and pCECs) from the GTKO pigs provided by the 
NSRRC appeared to have greater expression of NeuGc than WT pigs, but cells from GTKO 
pigs provided by Revivicor showed similar or even lower expression than WT pigs, but 
whether this difference is significant remains uncertain. Expression of NeuGc would need to 
be measured in various strains of pig using a quantifiable method.
These perceived different levels of NeuGc expression did not correlate with the extent of 
human antibody binding. Pigs from the NSRRC had higher NeuGc expression, but human 
antibody binding to the tissues or cells was not more than to those from Revivicor pigs. The 
variable level of NeuGc expression on pCECs and pAECs may therefore not be sufficiently 
different to show disparity in antibody binding. The differing backgrounds (strains) of the 
pigs or different techniques of genetic modification may have modified surface carbohydrate 
composition. The extent of antibody binding may also be influenced by the presence of anti-
nonGal, anti-nonNeuGc antibodies in the serum.
When using CECs as the target cells, there were no significant differences in human IgM or 
IgG binding to GTKO and GTKO/NeuGcKO CECs. There was minimal antibody binding to 
CECs from either GTKO or GTKO/NeuGcKO pigs; nevertheless, the binding of IgM was 
significantly higher than to human cells. There was no binding of IgG to all GTKO, GTKO/
NeuGcKO and human cells (rMFI =< 1). This result differs from that reported using 
PBMCs2,9 and AECs as target cells, which showed greater reduction in antibody binding to 
GTKO/NeuGcKO pig cells than to GTKO pig cells. This may possibly be explained by low 
immunogenicity of pig CECs compared to pig PBMCs and AECs16. Both Gal16 and NeuGc 
expression are significantly lower on CECs than on comparable AECs (mean rMFI of 
NeuGc level of pAECs =142.3 ±145.1 [n=7] vs. mean rMFI of NeuGc level of pCECs =9.24 
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±6.0 [n=7]; p=0.02). Removal of Gal epitopes alone appears to be sufficient to significantly 
reduce the humoral barrier to CECs, but not to AECs.
Whether human anti-NeuGc antibodies are less or more detrimental to a pig graft than anti-
Gal antibodies is uncertain. Although human anti-NeuGc antibodies have a lower IgM/IgG 
ratio and lower titers of pre-existing natural antibody, the presence of NeuGc epitopes on the 
pig corneal endothelium (where Gal is absent) may be important and may be associated with 
greater injury4. The in vivo human elicited antibody response to NeuGc has not been 
measured, but may be considerable, thus initiating rejection. Furthermore, the interactions of 
NeuGc with circulating anti-NeuGc antibodies may potentially incite inflammation27, and 
therefore the absence of NeuGc may reduce both the humoral and inflammatory barriers to 
corneal xenotransplantation. Long-term assessment of the relationship between NeuGc and 
inflammation will be necessary.
In summary, by reducing human xenoreactive antibody binding, the development of pigs 
deficient in both Gal and NeuGc may reduce immunologic and/or inflammatory injury to a 
pig corneal xenograft in humans (but not in Old World nonhuman primates, which express 
NeuGc), but will not prevent all antibody binding. Identification and deletion of other 
xenoantigens may be necessary to provide complete protection of a pig corneal xenograft.
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Figure 1. 
(A) Gal (green) expression on corneas by immunofluorescence WT pig corneas expressed 
Gal (largely on anterior stroma), whereas GTKO, GTKO/NeuGcKO, and human corneas 
were negative for Gal expression.
(B) NeuGc (red) expression on corneas by immunofluorescence Corneas from WT pigs and 
GTKO pigs of two different genetic backgrounds expressed NeuGc on the epithelial, 
stromal, and endothelial cells (and stroma), but NeuGc was not detectable on either GTKO/
NeuGcKO pig or human corneas.
(C) Expression of Gal and NeuGc on aortas Aortas from WT pigs expressed Gal on the 
endothelial cells (red arrows) and NeuGc. GTKO pigs of two different genetic 
backgrounds expressed NeuGc, but not Gal. Neither Gal nor NeuGc was detectable on 
GTKO/NeuGcKO pig aortas from two different genetic backgrounds. Figures are 
representative of at least 3 different experiments. (Magnification 200x; nuclei – blue; Gal – 
green; NeuGc – red).
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Figure 2. Gal and NeuGc expression on CECs (A, B) and AECs (C, D) by flow cytometry
(A, C) WT pCECs and pAECs expressed Gal whereas CECs and AECs from GTKO, 
GTKO/NeuGcKO, and human corneas and aortas did not. (B, D) WT and GTKO pCECs 
and pAECs expressed NeuGc to varying extents. NeuGc was not expressed on either GTKO/
NeuGcKO pig or human CECs and AECs. Figures are representative of experiments with 
WT cells (n=3), Revivicor GTKO cells (n=3), NSRRC GTKO cells (n=2), Indiana university 
GTKO/NeuGcKO cells (n=2), Revivicor GTKO/NeuGcKO cells (CECs; n=6, AECs; n=2 
respectively), and human cells (n=2). rMFI= relative mean fluorescence intensity
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Figure 3. Levels of NeuGc expression on CECs (A) and AECs (B) by flow cytometry
(A, B) The level of NeuGc expression of pCECs and pAECs from different sources differed. 
Expression of NeuGc on CECs of NSRRC GTKO pigs appeared to be higher than on CECs 
of Revivicor GTKO pigs. Statistical analysis was not possible due to the small number of 
samples tested. Figures are from different samples from WT pigs (n=3), Revivicor GTKO 
pigs (n=3), NSRRC GTKO pigs (n=2), Indiana university GTKO/NeuGcKO pigs (n=2), 
Revivicor GTKO/NeuGcKO pigs (CECs; n=6, AECs; n=2 respectively), and humans (n=2). 
rMFI= relative mean fluorescence intensity
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Figure 4. Human antibody binding to pig and human corneas by immunofluorescence
(A) Human IgM binding to corneas after co-culture with 20% pooled human serum. 
Compared to binding to WT corneas, human IgM binding to GTKO corneas was decreased 
and further decreased to GTKO/NeuGcKO corneas. However, there was still some binding, 
especially in the limbal area. There was minimal IgM binding to a human cornea.
(B) Human IgG binding to corneas after co-culture with 5% pooled human serum. 
Compared to binding to WT corneas, human IgG binding to GTKO corneas was decreased 
and further decreased to GTKO/NeuGcKO corneas. There was minimal IgG binding to a 
human cornea.
(C) Human IgM and IgG binding to aortas after co-culture with pooled human serum (20% 
for IgM and 5% for IgG respectively)
Compared to binding to WT aortas, human IgM/IgG binding to GTKO aorta was decreased, 
and further decreased to GTKO/NeuGcKO aortas, particularly to the aortic endothelium.
Figures are representative of at least 3 different experiments. (Magnification 200x; nuclei – 
blue; IgM - green, IgG – green)
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Figure 5. Human IgM and IgG antibody binding to CECs (A and B) and AECs (C and D) by 
flow cytometry using different individual human sera
(A) Human IgM binding to WT pCECs was variable, but binding to GTKO and GTKO/
NeuGcKO pig CECs and to human CECs was significantly decreased (n=6, *p<0.05). 
Binding of human IgM antibody to human CECs was significantly lower than to all other 
pCECs (*p<0.05). There was no significant difference in binding to GTKO and GTKO/
NeuGcKO pCECs.
(B) Human IgG binding to WT CECs was variable, but binding to GTKO, GTKO/
NeuGcKO, or human CECs was significantly decreased (n=6, *p<0.05). There was no 
significant difference in binding to GTKO, GTKO/NeuGcKO, and human CECs. (C) Human 
IgM binding to WT pAECs was variable, but binding to GTKO and GTKO/NeuGcKO 
pAECs was significantly decreased (n=6, *p<0.05). There was no significant difference in 
IgM binding to pAECs from GTKO pigs of the two different genetic backgrounds, but 
binding to GTKO pAECs was significantly greater than to GTKO/NeuGcKO pAECs (* 
p<0.05; ns=not significant). There was no significant difference in IgM binding to pAECs 
from GTKO/NeuGcKO pigs of the two different genetic backgrounds. Binding of human 
IgM antibody to human CECs was significantly lower than to all other pCECs (* p<0.05).
(D) Human IgG binding to WT and GTKO pAECs and was variable, but almost no binding 
to GTKO/NeuGcKO pAECs was detected. Compared to WT pAECs, human IgG binding to 
GTKO and GTKO/NeuGcKO pAECs was significantly decreased (n=6, * p<0.05). There 
was no significant difference in IgG binding to GTKO pAECs of the two different genetic 
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backgrounds, but binding to GTKO pAECs was significantly greater than to GTKO/
NeuGcKO pAECs (* p<0.05; ns=not significant). There was no significant difference in IgG 
binding to pAECs from GTKO/NeuGcKO pigs of the two different genetic backgrounds.
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